MAPT and Alzheimer disease: Our research suggests that demyelination may lead to the impairment of neuronal transport, and decreased expression of neurofilament proteins and synaptic protein, but not cause AD-like hyperphosphorylated tau, increased level of beta amyloid and neuronal loss.